While Bitcoin's sharp correction to nine-month lows triggered massive liquidations and ETF outflows, a deeper look reveals sustained corporate accumulation, state-level adoption proposals, and expanding bank services—painting a picture of a maturing asset class weathering short-term volatility.
A historic rally in gold and silver reversed violently on Friday, with gold futures plummeting over 10% in their sharpest decline since the 1980s and silver recording its largest single-day drop ever, amid a broader market sell-off.
Gold and silver prices retreated sharply from record highs as President Trump's nomination of Kevin Warsh to lead the Federal Reserve eased concerns over central bank independence, triggering a broad profit-taking sell-off.
Gold and silver futures plummeted Friday, erasing recent gains in a dramatic reversal. The sharp decline coincided with broader market jitters and followed warnings that the metals' explosive rally had entered unsustainable territory.
Beazer Homes USA reported a steeper-than-expected quarterly loss, with revenue falling 22% amid a challenging housing market characterized by soft demand and aggressive competitor pricing.
A stunning reversal wiped out months of gains for precious metals on Friday, with gold futures tumbling to $4,800 and silver recording a historic single-day drop, sparking fears of a volatile new phase for commodity markets.
Brookfield Business Partners (BBU) reports a strong 2025 defined by strategic capital moves and operational gains across its portfolio. The company is on the cusp of a major corporate reorganization into a single listed entity, aiming to boost liquidity and attract a wider investor base.
Despite reporting strong quarterly earnings, Microsoft shares suffered one of their worst single-day drops in history as investors balked at soaring capital expenditures for AI infrastructure and signs of slowing growth in its Azure cloud division.
A dramatic rally in gold and silver prices came to an abrupt halt on Friday, with futures tumbling sharply amid a broader market sell-off and warnings of unsustainable volatility.
Quarterhill Inc. (TSE:QTRH) shareholders have endured a punishing five-year period, with the stock's value plummeting nearly 70%. Despite modest revenue growth, the market's verdict has been harsh, raising questions about the company's path to profitability and the perils of long-term bets in turbulent sectors.
Despite posting robust quarterly earnings, Microsoft shares tumbled over 10% as investors balked at rising costs and a cautious outlook, raising questions about the sustainability of its AI-driven growth narrative.
A blistering rally in gold and silver came to an abrupt halt Friday, with prices tumbling sharply as market volatility surged and analysts warned the historic run may be entering a precarious phase.
A wave of risk aversion sweeps global markets, dragging cryptocurrencies down sharply. Bitcoin's technical breakdown and a steep drop for Worldcoin highlight a day of heavy losses and liquidations.
A disappointing full-year EBITDA performance from its crucial Macau operations triggered a sharp sell-off in Las Vegas Sands stock, underscoring the lingering challenges facing the gaming giant in the wake of China's regulatory crackdown.
Asian markets opened to a volatile session Friday, with Bitcoin leading a sharp crypto sell-off and stocks swinging as traders weighed President Trump's signals on a key Fed nomination and a deal to avert a government shutdown.
Gold prices staged a significant recovery on Tuesday, regaining some ground after a historic two-day sell-off. The focus now shifts to Chinese retail investors, whose appetite for bargain-hunting ahead of the Lunar New Year could be pivotal for the market's near-term direction.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Once a high-flying adtech darling, The Trade Desk has seen its stock crater nearly 80% from its peak amid a fierce battle with Amazon's ad juggernaut. With shares now trading at a significant discount to the market, analysts are divided on whether this marks a historic buying opportunity or signals deeper structural challenges.
Crude oil and gasoline futures tumbled sharply on Monday, pressured by a rallying U.S. dollar and signs of diplomatic engagement between the U.S. and Iran. The sell-off marks a significant reversal from last week's geopolitical premium.
